Research Calls I
-
Upgrades:
- Baozun (BZUN) upgraded to Outperform from Hold at CLSA, tgt $3.80
- Element Solutions (ESI) upgraded to Buy from Hold at Freedom Capital, tgt $48
- Enbridge (ENB) upgraded to Outperformer from Neutral at CIBC
- Evolution Petroleum (EPM) upgraded to Outperform from Market Perform at Northland, tgt $4
- Moderna (MRNA) upgraded to Buy from Hold at Argus; tgt $180
- Petrobras (PBR) upgraded to Outperform from Neutral at Bradesco BBI, tgt $20
- Baozun (BZUN) upgraded to Outperform from Hold at CLSA, tgt $3.80
-
Downgrades:
- Allstate (ALL) downgraded to Hold from Buy at Argus
- VTEX (VTEX) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $4
- Workday (WDAY) downgraded to Equalweight from Overweight at Capital One, tgt $219
-
Others:
- CapsoVision (CV) resumed with a Buy at Roth Capital, tgt $9
- Metals Royalty Company (TMCR) initiated with a Buy at Stifel, tgt $10
- Rhythm Pharmaceuticals (RYTM) initiated with a Hold at Deutsche Bank, tgt $120
- TeraWulf (WULF) initiated with an Outperform at William Blair
- The Metals Company (TMC) initiated with a Buy at Stifel, tgt $10
- UMB Financial (UMBF) resumed with an Outperform at Raymond James, tgt $165
- Octave Specialty Group (Ambac) (OSG) initiated with an Outperform at Keefe Bruyette, tgt $8
- CapsoVision (CV) resumed with a Buy at Roth Capital, tgt $9